The Technical AnalystExchange: SHZ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Jiuzhitang Co., Ltd. Price, Forecast, Insider, Ratings, Fundamentals & Signals
1.95% CNY7.85
America/New_York / 30 apr 2024 @ 03:04
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 6 719.14 mill |
| EPS: | 0.330 |
| P/E: | 23.79 |
| Earnings Date: | May 17, 2024 |
| SharesOutstanding: | 855.94 mill |
| Avg Daily Volume: | 10.80 mill |
| RATING 2024-04-30 |
|---|
| A |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Neutral | |
| P/E: | Neutral | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.66x |
| Company: PE 23.79 | sector: PE 35.84 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.52x |
| Company: PE 23.79 | industry: PE 45.57 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
CNY8.75 (11.41%) CNY0.896 |
| Date: 2024-05-05 |
| Expected Trading Range (DAY) |
|---|
|
CNY 7.64 - 8.06 ( +/- 2.64%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | CNY7.85 (1.95% ) |
| Volume | 76.12 mill |
| Avg. Vol. | 10.80 mill |
| % of Avg. Vol | 704.95 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 000989.SZ
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
000989.SZ
Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. The company offers shuxuetong injections, Angong Niuhuang Wan, Danxi granules, and Gastrodia Uncaria for cardiovascular and cerebrovascular disease; Guizhi Fuling pills, Buxue Shengru granules, and hemostasis and analgesia products for gynecological disease; Schicon for respiratory disease; and Jiaqi Ganzian granules, Jianwei Yuyang tablets, Jienchang Ning, and Chidan yellowing products for digestive disease. It also provides non-prescription drugs for treating nourishing QI and blood, cardiovascular and cerebrovascular, urinary system, pediatric, gynecological, skeletal muscle, respiratory, dermatology, nervous system, ENT, digestive system, and tumor diseases. Jiuzhitang Co., Ltd. was founded in 1999 and is headquartered in Beijing, China.